Joel M Neutel Selected Research

Hydrochlorothiazide (Esidrix)

9/2017	Comparison of long-term safety of fixed-dose combinations azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide.
9/2014	Telmisartan in combination with hydrochlorothiazide 12.5 mg for the management of patients with hypertension.
11/2012	Efficacy of amlodipine/olmesartan medoxomil ± HCTZ in obese patients uncontrolled on antihypertensive monotherapy.
10/2012	Efficacy of olmesartan medoxomil and hydrochlorothiazide fixed-dose combination therapy in patients aged 65 years and older with stage 1 and 2 hypertension or isolated systolic hypertension.
9/2011	Seated cuff blood pressure-lowering efficacy of an olmesartan medoxomil-based treatment regimen in patients with type 2 diabetes mellitus.
7/2011	A comparison of the efficacy and safety of irbesartan/hydrochlorothiazide combination therapy with irbesartan monotherapy in the treatment of moderate or severe hypertension in diabetic and obese hypertensive patients: a post-hoc analysis review.
6/2011	A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil ± hydrochlorothiazide.
5/2011	Management of hypertension in patients with diabetes using an amlodipine-, olmesartan medoxomil-, and hydrochlorothiazide-based titration regimen.
7/2010	Efficacy and safety of irbesartan/HCTZ in severe hypertension according to cardiometabolic factors.
3/2010	Effects of an olmesartan medoxomil based treatment algorithm on 24-hour blood pressure control in patients with hypertension and type 2 diabetes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joel M Neutel Research Topics

Disease

49	Hypertension (High Blood Pressure) 12/2014 - 01/2002
13	Type 2 Diabetes Mellitus (MODY) 01/2018 - 10/2005
9	Isolated Systolic Hypertension 10/2012 - 12/2004
5	Essential Hypertension 09/2017 - 09/2002
4	Dyslipidemias (Dyslipidemia) 05/2014 - 08/2006
4	Edema (Dropsy) 08/2010 - 06/2002
3	Dizziness (Lightheadedness) 09/2017 - 04/2009
3	Headache (Headaches) 09/2017 - 08/2008
3	Hypercholesterolemia 06/2014 - 04/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 04/2014 - 01/2002
2	Hypotension (Low Blood Pressure) 10/2012 - 01/2009
2	Obesity 07/2011 - 12/2007
1	Hyperglycemia 01/2018
1	Nasopharyngitis 09/2017
1	Back Pain (Backache) 05/2014
1	Spasm (Spasms) 05/2014
1	Pain (Aches) 05/2014
1	Arthralgia (Joint Pain) 05/2014
1	Coronary Disease (Coronary Heart Disease) 06/2010
1	Respiratory Tract Infections (Respiratory Tract Infection) 04/2009
1	Kidney Diseases (Kidney Disease) 12/2007
1	Gout 01/2007
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2006
1	Cough 01/2006
1	Diastolic Heart Failure 12/2004
1	Orthostatic Hypotension (Postural Hypotension) 01/2004

Drug/Important Bio-Agent (IBA)

28	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 09/2017 - 01/2002
22	Antihypertensive Agents (Antihypertensives)IBA 10/2013 - 01/2002
16	Olmesartan Medoxomil (Votum)FDA Link 09/2017 - 09/2002
14	Amlodipine (Norvasc)FDA LinkGeneric 12/2012 - 06/2002
11	Irbesartan FDA LinkGeneric 07/2011 - 09/2005
9	Angiotensin Receptor AntagonistsIBA 03/2009 - 09/2003
8	Telmisartan (Micardis)FDA Link 09/2014 - 01/2002
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2014 - 01/2009
4	Pharmaceutical PreparationsIBA 10/2012 - 01/2004
4	benazepril (Briem)FDA LinkGeneric 01/2007 - 06/2002
3	evolocumabIBA 06/2014 - 04/2014
3	Ezetimibe (Zetia)FDA Link 06/2014 - 04/2014
3	oxidized low density lipoproteinIBA 06/2014 - 04/2014
3	Losartan (Cozaar)FDA LinkGeneric 11/2005 - 01/2002
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 12/2013
2	Valsartan (Vals)FDA Link 12/2014 - 09/2006
2	LDL CholesterolIBA 04/2014 - 06/2010
2	atorvastatin drug combination amlodipine FDA Link 06/2010 - 01/2009
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 03/2009 - 01/2009
2	Atorvastatin (Lipitor)FDA Link 01/2009 - 08/2006
2	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 12/2007 - 09/2006
2	olmesartanIBA 01/2007 - 01/2004
2	hydrochlorothiazide drug combination telmisartanIBA 11/2005 - 07/2005
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	CarbohydratesIBA 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	CreatinineIBA 09/2017
1	Chlorthalidone (Chlortalidone)FDA LinkGeneric 09/2017
1	azilsartan medoxomilIBA 09/2017
1	Nebivolol FDA Link 12/2014
1	Metformin (Glucophage)FDA LinkGeneric 12/2013
1	saxagliptin FDA Link 12/2013
1	telmisartan amlodipine combination FDA Link 04/2012
1	Olmesartan Medoxomil Drug Combination Amlodipine Besylate FDA Link 08/2010
1	CholesterolIBA 06/2010
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 06/2009
1	Phosphodiesterase 5 InhibitorsIBA 06/2009
1	PF-00489791IBA 06/2009
1	lipoprotein cholesterolIBA 01/2009
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2007
1	Uric Acid (Urate)IBA 01/2007
1	Ramipril (Altace)FDA LinkGeneric 01/2006
1	alagebriumIBA 12/2004
1	Propranolol (Inderal)FDA LinkGeneric 05/2004
1	propranolol CR FDA Link 05/2004
1	Perindopril FDA LinkGeneric 01/2004
1	Diltiazem (Cardizem)FDA LinkGeneric 01/2003
1	Therapeutic UsesIBA 01/2002

Therapy/Procedure

28	Therapeutics 12/2014 - 01/2002
1	Enteral Nutrition (Feeding, Tube) 01/2018
1	Combination Drug Therapy (Combination Chemotherapy) 01/2002